Research | Star Retina

Research

 

Clinical Research Trials

Retinal diseases are a leading cause of vision loss and blindness, affecting millions of people worldwide. Clinical trials are vital to the development of new treatments and therapies for these conditions, and there are many ongoing trials testing promising new approaches.

Star Retina is proud to take part in clinical research trials for many common retinal conditions. Below are trials for which we are currently enrolling new patients and those that have been completed.

Wet AMD / Neovascular AMD

  • Artemis Current
    Adverum | ADVM-022-12
    Method: Suprachoroidal eye injection
  • Lucia Current
    EyePoint | EYP-1901-302
    Method: Intravitreal implant + eye injection
  • Daybreak Current
    Kodiak | KS301P109
    Method: Intravitreal eye injection
  • SOL-1 Current
    Ocular Therapeutix | OTX-TKI-2023-AMD-301
    Method: Intravitreal implant + eye injection
  • SOL-R Current
    Ocular Therapeutix | OTX-TKI-2023-AMD-303
    Method: Intravitreal implant + eye injection
  • Achieve Current
    AbbVie | M24-528
    Method: Suprachoroidal eye injection
    History: Experienced
  • Atmosphere Current
    AbbVie | RGX-314-2104
    History: Experienced
  • Ascent Current
    AbbVie | RGX-314-3101
    History: Experienced
  • Crossover Current
    AbbVie | RGX-314-5101
  • NOVA1 Current
    Alcon | RTE888-E001
    Method: Intravitreal implant
  • STAT Upcoming
    Syneos | ocul101-002
    Method: Intravitreal eye injection
  • SOL-X Upcoming
    Ocular Therapeutix | OTX-TKI-2025-AMD-301
    Method: Intravitreal eye injection
  • SAHARA Upcoming
    Ollin Biosciences | OLN324-CP-05
    Method: Intravitreal eye injection

Diabetic Macular Edema (DME)

  • Barolo Current
    EyeBio | EYE-RES-103
    Method: Intravitreal eye injection
  • ATACAMA Upcoming
    Ollin Biosciences | OLN324-CP-02
    Method: Intravitreal eye injection
  • BI 1485-0018 Upcoming
    IQVIA | BI 1485-0018
    Method: Oral medication
  • NAAVIGATE Upcoming
    AbbVie | M23-415
    Method: Suprachoroidal eye injection
  • SYRAH*** Upcoming
    Merck & Co | MK-8748-005
    Method: Intravitreal eye injection
  • Diamond 2 Completed
    Oculis | DX221

Retinal Vein Occlusion / Multi-Indication

  • Kalaris Current
    Kalaris Therapeutics | KLRS-100
    Method: Intravitreal eye injection
    History: Naive arm
  • Kalaris Upcoming
    Kalaris Therapeutics | KLRS-100
    Method: Intravitreal eye injection
    History: Naive arm
  • Super Tuscan Completed
    EyeBio | EYE-RES-104
    Method: Intravitreal eye injection

Retinal Vein Occlusion

  • MK-8748-006 Upcoming
    Merck & Co | MK-8748-006
    Method: Intravitreal eye injection

Geographic Atrophy / Dry AMD

  • Journey Current
    Perceive Bio | PBI-AMD-002
    Method: Intravitreal eye injection
  • Sahara Current
    Ollin Biosciences | OLN324-CP-05
  • Sienna Current
    Regeneron | R3918-AMD-2326
  • Sitala Bio Current
    IQVIA Biotech | STL303-202
    Method: Oral medication
  • Astellas Upcoming
    Astellas Institute for Regenerative Medicine (AIRM) | 7317-CL-0008
    Method: Subretinal surgical injection
  • Genentech Upcoming
    Genentech, Inc. | XR46785
    Method: Intravitreal eye injection
  • 7317-CL-0009 Upcoming
    Astellas Pharma | 7317-CL-0009
  • CTX114-CS201 Upcoming
    Syneos | CTX114-CS201
    Method: Intravitreal eye injection
  • CTX203-CS201 Upcoming
    CTX203-CS201
    Method: Intravitreal eye injection
  • ReBuild Upcoming
    Mighty Therapeutics | MYTX272AM-201
    Method: Eye drops
  • Sitala Upcoming
    Sitala Bio | STL303-202
    Method: Oral medication
  • Nirvana Completed
    Perceive Bio | PBI-AMD-NH1

Diabetic Retinopathy (DR)

  • HELIOS-3 Current
    Ocular Therapeutix | OTX-TKI-2025-NPDR-302
    Method: Intravitreal implant + eye injection
  • Altitude Current
    AbbVie | RGX-314-2202
  • NAAVIGATE Current
    AbbVie | M23-415
  • LTFU Current
    AbbVie | RGX-314-5201
  • AP Upcoming
    DRCR
  • Helios-3 Upcoming
    Ocular Therapeutix | OTX-TKI-2025-NPDR-302
    Method: Intravitreal implant
  • Glow2 Completed
    Kodiak | KS301P108
    Method: Intravitreal eye injection

Other / Not Specified

  • Hunter Upcoming
    Astellas Pharma | 3021-CL-3003
  • AM Upcoming
    DRCR
  • LTFU Upcoming
    AbbVie | RGX-314-5201

Stargardt Disease

  • NORTHSTAR Current
    Alkeus Pharmaceuticals | ALK001-P1004
    Method: Oral medication

Trial availability and eligibility change often. Please call our office at 817-378-4777 to confirm whether a study is right for you or your patient.

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.